India  

"Maiden Pharmaceuticals"

Latest news and video coverage curated from trusted media outlets

0
shares
ShareTweetSavePostSend
 
WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International [Video]

WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International

The World Health Organisation on Wednesday warned that four "contaminated" and "substandard" cough syrups, allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonipat could be the..

Credit: Oneindia     Duration: 02:22Published

You Might Like


Gambia cough syrup deaths: Govt panel says info shared by WHO so far inadequate to determine aetiology

Rutendo Kuwana from the WHO on October 13 had written to the DCGI seeking to know the progress with the investigation of the manufacturer of the four cough syrups -- the Sonipat-based Maiden..
Zee News - Published

Gambia Children Death Case: India-made cough syrup allegedly kills 66 children in Africa - all you need to know

Gambia child death case: The  World Health Organisation has issued alerts of India-made Maiden Pharmaceuticals Limited cough syrup "potentially linked with acute kidney injuries and 66 children`s..
Zee News - Published

Govt forms panel to probe WHO report on kids' deaths in Gambia

The Centre on Wednesday formed a four-member committee to examine details and 'adverse event' reports received from the WHO on the deaths of 66 children in Gambia that are being linked potentially to..
IndiaTimes - Published

Centre forms four-member expert team to probe WHO claims on Maiden Pharmaceuticals

LHI: The Central Government on Wednesday formed a four-member expert committee to investigate the report sent by the World Health Organisation (WHO) on the deaths of 66 children in Gambia by..
IndiaTimes - Published

Haryana minister Anil Vij says Maiden Pharmaceuticals asked to shut production of cough syrups after WHO alert

Health Minister Anil Vij said the samples of the three syrups have been sent for chemical analysis at the Central Drug Laboratory in Kolkata.
DNA - Published

Maiden Pharma may lose import-export licence over cough syrup controversy in Gambia

The suspension of membership implies that Maiden Pharmaceuticals will not be eligible to receive any incentives.
DNA - Published

Maiden Pharma under scrutiny after 66 children died consuming cough syrup in Gambia

The drug regulators have obtained samples of cold and cough medicine from Maiden Pharmaceuticals in response to a WHO medical alert.
DNA - Published

Firm behind Gambia child deaths a repeat offender in India

The Central Drug Standard Control Organisation (CDSCO) has been quick to assure people that the cough syrup which killed 66 children in Gambia was not being sold locally in India, but the same company,..
IndiaTimes - Published

Centre monitoring, taking updates from state regulatory agencies about Maiden Pharmaceuticals Ltd, its products


newKerala.com - Published

DO NOT use them: WHO issues alert on four cough syrups made by India's Maiden Pharmaceuticals


newKerala.com - Published Also reported by •Zee NewsIndiaTimes

With raids and show-cause notice, govt plans mega crackdown on cough syrup maker under WHO lens over Gambia deaths

The WHO warned that four cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths of 66 children in The Gambia.
DNA - Published

Gambia children deaths: What is Maiden Pharmaceuticals Limited and who owns the company? What are WHO's allegations?

India's drug regulator, meanwhile, has launched a probe into WHO's allegations.
DNA - Published

WHO alert on 4 Indian cough syrups as 66 Gambian kids die

The WHO on Wednesday issued a medical product alert on four ‘cough & cold’ syrups made by an Indian pharmaceutical firm — Maiden Pharmaceuticals Ltd, Sonipat, Haryana — warning they could be..
IndiaTimes - Published